Literature DB >> 26707588

Modulatory role of 17β-estradiol in the tumor microenvironment of thyroid cancer.

Sithul Hima1, Sreeharshan Sreeja1.   

Abstract

Thyroid cancer (TC) is an endocrine related cancer and is well coupled with the female reproductive hormone, 17β-estradiol (estrogen). Plenty of articles have discussed the role of tumor microenvironment (TME) with different types of tumors in a broad-spectrum but the role of female reproductive hormone, that is, involvement of estrogen in TME of TC have not been reviewed elsewhere. The aim of this review is to analyze how 17β-estradiol affects the TME of TC and also that subsequently leads to progression of cancer. This review is given a new insight on: 1) the estrogen's involvement in TME of TC; 2) how it interferes with the complex cross talk of signaling pathways established between cancer cells, host cells, and their surrounding extracellular matrix; and 3) the important factors of microenvironment comprising inflammation, hypoxia, angiogenesis, metastasis, various growth factors and fibroblasts in stromal cells.
© 2015 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  estrogen; thyroid cancer; tumor microenvironment

Mesh:

Substances:

Year:  2015        PMID: 26707588     DOI: 10.1002/iub.1462

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  7 in total

1.  Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior.

Authors:  Yu-Jie Dai; Yi-Bo Qiu; Rong Jiang; Man Xu; Ling-Yao Liao; George G Chen; Zhi-Min Liu
Journal:  Cell Oncol (Dordr)       Date:  2018-01-24       Impact factor: 6.730

2.  Thyroid nodule recurrence following lobo-isthmectomy: incidence, patient's characteristics, and risk factors.

Authors:  M C Zatelli; L Lamartina; D Meringolo; E Arvat; L Damiani; G Grani; A Nervo; C Durante; L Giacomelli
Journal:  J Endocrinol Invest       Date:  2018-09-04       Impact factor: 4.256

3.  Concomitant high expression of ERα36, EGFR and HER2 is associated with aggressive behaviors of papillary thyroid carcinomas.

Authors:  Yu-Jie Dai; Yi-Bo Qiu; Rong Jiang; Man Xu; Le Zhao; George G Chen; Zhi-Min Liu
Journal:  Sci Rep       Date:  2017-09-25       Impact factor: 4.379

4.  Identification of genes of prognostic value in the ccRCC microenvironment from TCGA database.

Authors:  Bangbei Wan; Bo Liu; Yuan Huang; Cai Lv
Journal:  Mol Genet Genomic Med       Date:  2020-02-03       Impact factor: 2.183

5.  Evaluation of the relationship between previous statin use and thyroid cancer using Korean National Health Insurance Service-Health Screening Cohort data.

Authors:  So Young Kim; Young Shin Song; Jee Hye Wee; Chanyang Min; Dae Myoung Yoo; Chang-Ho Lee; Chang Myeon Song; Bumjung Park; Hyo Geun Choi
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

Review 6.  A Role for Estrogen Receptor alpha36 in Cancer Progression.

Authors:  Maria Teresa Pagano; Elena Ortona; Maria Luisa Dupuis
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-31       Impact factor: 5.555

7.  Cervical carcinoma high-expressed long non-coding RNA 1 promotes papillary thyroid carcinoma cell proliferation and invasion.

Authors:  Ping Shi; Yan Liu; Mingzeng Zhang; Jianwang Yang; Shanghua Jing; Dongqiang Yang; Fei Liu; Yanzhao Wu; Huijing Shi; Cuizhi Geng
Journal:  Transl Cancer Res       Date:  2021-09       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.